LeMaitre Vascular, Inc. (FRA:LHU)

Market Cap	1.57B -10.6%
Revenue (ttm)	229.71M +11.8%
Net Income	57.48M +39.4%
EPS	2.50 +39.4%
Shares Out	n/a
PE Ratio	27.36
Forward PE	25.34
Dividend	0.82 (1.22%)
Ex-Dividend Date	Aug 20, 2026

Volume	n/a
Open	68.50
Previous Close	70.00
Day's Range	67.00 - 68.50
52-Week Range	66.00 - 99.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2026

About LeMaitre Vascular

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheter...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1983
• Employees: 655
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: LHU

Financial Performance

In 2025, LeMaitre Vascular's revenue was $249.60 million, an increase of 13.53% compared to the previous year's $219.86 million. Earnings were $57.73 million, an increase of 31.10%.

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 18, 2026

Data Sources Report a data error